IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the seven research firms that are currently covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12 […]
IGM Biosciences, Inc. (NASDAQ:IGMS – Free Report) Director M Kathleen Behrens bought 112,500 shares of the stock in a transaction on Monday, June 26th. The shares were acquired at an average cost of $8.00 per share, for a total transaction of $900,000.00. Following the purchase, the director now owns 330,700 shares in the company, valued […]
IGM Biosciences, Inc. (NASDAQ:IGMS – Get Rating)’s stock price gapped up prior to trading on Tuesday . The stock had previously closed at $25.33, but opened at $25.99. IGM Biosciences shares last traded at $24.67, with a volume of 58 shares changing hands. Wall Street Analyst Weigh In A number of equities research analysts have […]